Inland Psychiatric Medical Group.

Chino, California 91710

6 studies enrolling now · 8 studies all time

What they study most

Agitation, Alzheimer Disease, Atherosclerotic Cardiovascular Disease, Autism-Related Irritability, Bipolar Disorder, Depressive Disorder, Treatment-Resistant, Major Depressive Disorder (MDD), Mania, Primary Prevention of Atherosclerotic Cardiovascular Disease, Psychosis, Schizophrenia

Studies at this site

• ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response — Recruiting now
• A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively — Recruiting now
• A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN) — Recruiting now
• A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5) — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine — Recruiting now
• Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling